Cellectar Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,423 | 0.0151% |
Individual Insiders | 1,147,880 | 3.2% |
VC/PE Firms | 2,804,917 | 7.82% |
Institutions | 4,672,929 | 13% |
Hedge Funds | 5,179,261 | 14.4% |
General Public | 22,038,514 | 61.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 268%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,305,936 | US$9.5m | 64.8% | 8.12% | |||
2,804,917 | US$8.0m | 46.5% | 3.69% | |||
1,873,325 | US$5.4m | 38.7% | 0.58% | |||
1,191,081 | US$3.4m | 147% | no data | |||
897,605 | US$2.6m | 0% | no data | |||
847,647 | US$2.4m | -35.2% | 57.72% | |||
642,541 | US$1.8m | -53.4% | 0.58% | |||
338,198 | US$967.2k | 0% | no data | |||
316,084 | US$904.0k | 359% | no data | |||
150,000 | US$429.0k | 0% | no data | |||
143,500 | US$410.4k | -70% | 0.31% | |||
142,382 | US$407.2k | 150% | no data | |||
138,761 | US$396.9k | 0% | 0.02% | |||
117,689 | US$336.6k | 70.6% | no data | |||
105,414 | US$301.5k | 571% | no data | |||
98,500 | US$281.7k | 0% | no data | |||
59,420 | US$169.9k | 0% | no data | |||
55,038 | US$157.4k | 0% | no data | |||
53,141 | US$152.0k | 0% | no data | |||
52,351 | US$149.7k | 313% | no data | |||
49,218 | US$140.8k | -0.04% | no data | |||
44,643 | US$127.7k | 112% | no data | |||
42,578 | US$121.8k | 0% | no data | |||
39,599 | US$113.3k | 0% | no data | |||
36,025 | US$103.0k | 0% | no data |